Estimated absolute reductions in 15-year breast cancer mortality were 1.6% for women with zero positive axillary nodes, 2.7% for those with one to three positive axillary nodes, and 4.5% for those with four or more positive axillary nodes.[20] Postoperative chest wall and regional lymph node adjuvant radiation therapy has traditionally been given to selected patients considered at high risk of locoregional failure after mastectomy.
Patients at highest risk of local recurrence meet one or more of the following criteria:[21-23] Four or more positive axillary nodes.
Grossly evident extracapsular nodal extension.